MoS₂ precursors were synthesized by reacting thioacetamide ( C₂H₅NS ) with sodium molybdate dihydrate ( Na₂MoO₄·2H₂O ) in aqueous HCl solution. MoS₂ nanoparticles were prepared from dried MoS₂ precursors by calcination in an electric furnace at 700∘C for 2 h under an inert argon atmosphere. MoS₂-C₆₀ nanocomposites were obtained by heating MoS₂ nanoparticles and fullerene ( C₆₀ ) together in an electric furnace at 700∘C for 2 h. Their morphological and the structural properties were characterized by powder X-ray diffraction and scanning electron microscopy. The MoS₂ nanoparticles and MoS₂-C₆₀ nanocomposites were used as catalysts in the reductions of 2-, 3-, and 4-nitrophenol in the presence of sodium borohydride. The photocatalytic activities of the MoS₂ nanoparticles and MoS₂-C₆₀ nanocomposites were evaluated in the degradation of organic dyes (brilliant green, methylene blue, methyl orange, and rhodamine B) under ultraviolet light (254 nm).
No takes yet. Share an insight, caveat, or question.
Li et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: